Cancer biology in diabetes update: Focusing on antidiabetic drugs

被引:1
作者
Kawakita, Emi [1 ]
Kanasaki, Keizo [1 ,2 ]
机构
[1] Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Japan
[2] Shimane Univ, Fac Med, Ctr Integrated Kidney Res & Adv, Izumo, Japan
基金
日本学术振兴会;
关键词
Antidiabetic drugs; Cancer; Diabetes; GLUCAGON-LIKE PEPTIDE-1; RANDOMIZED PHASE-II; ACTING INSULIN ANALOGS; ALL-CAUSE MORTALITY; BLADDER-CANCER; COLORECTAL-CANCER; CARDIOVASCULAR OUTCOMES; PANCREATIC-CANCER; BREAST-CANCER; PIOGLITAZONE USE;
D O I
10.1111/jdi.14152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The association of type 2 diabetes with certain cancer risk has been of great interest for years. However, the effect of diabetic medications on cancer development is not fully understood. Prospective clinical trials have not elucidated the long-term influence of hypoglycemic drugs on cancer incidence and the safety for cancer-bearing patients with diabetes, whereas numerous preclinical studies have shown that antidiabetic drugs could have an impact on carcinogenesis processes beyond the glycemic control effect. Because there is no evidence of the safety profile of antidiabetic agents on cancer biology, careful consideration would be required when prescribing any medicines to patients with diabetes and existing tumor. In this review, we discuss the potential influence of each diabetes therapy in cancer 'initiation', 'promotion' and 'progression'. The long-term influence of antidiabetic drugs use on cancer biology is not fully elucidated. We summarize and discuss the potential influence of each diabetes therapy in cancer 'initiation', 'promotion' and 'progression'. image
引用
收藏
页码:525 / 540
页数:16
相关论文
共 187 条
[41]   The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers [J].
DuBois, RN ;
Gupta, R ;
Brockman, J ;
Reddy, BS ;
Krakow, SL ;
Lazar, MA .
CARCINOGENESIS, 1998, 19 (01) :49-53
[42]   Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study [J].
Dujic, Tanja ;
Zhou, Kaixin ;
Donnelly, Louise A. ;
Tavendale, Roger ;
Palmer, Colin N. A. ;
Pearson, Ewan R. .
DIABETES, 2015, 64 (05) :1786-1793
[43]   Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies [J].
Elashoff, Michael ;
Matveyenko, Aleksey V. ;
Gier, Belinda ;
Elashoff, Robert ;
Butler, Peter C. .
GASTROENTEROLOGY, 2011, 141 (01) :150-156
[44]   Observational follow-up of the PROactive study: a 6-year update [J].
Erdmann, E. ;
Song, E. ;
Spanheimer, R. ;
de Bruyn, A. -R. van Troostenburg ;
Perez, A. .
DIABETES OBESITY & METABOLISM, 2014, 16 (01) :63-74
[45]   Metformin and reduced risk of cancer in diabetic patients [J].
Evans, JMM ;
Donnelly, LA ;
Emslie-Smith, AM ;
Alessi, DR ;
Morris, AD .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503) :1304-1305
[46]   Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins? A French nationwide cohort study based on national administrative databases [J].
Fagot, Jean-Paul ;
Blotiere, Pierre-Olivier ;
Ricordeau, Philippe ;
Weill, Alain ;
Alla, Francois ;
Allemand, Hubert .
DIABETES CARE, 2013, 36 (02) :294-301
[47]   Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models [J].
Farmer, Ruth E. ;
Ford, Deborah ;
Mathur, Rohini ;
Chaturvedi, Nish ;
Kaplan, Rick ;
Smeeth, Liam ;
Bhaskaran, Krishnan .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (02) :527-537
[48]  
Farmer RE, 2017, INT J EPIDEMIOL, V46, P728, DOI 10.1093/ije/dyw275
[49]   Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes [J].
Ferrara, Assiamira ;
Lewis, James D. ;
Quesenberry, Charles P., Jr. ;
Peng, Tiffany ;
Strom, Brian L. ;
Van den Eeden, Stephen K. ;
Ehrlich, Samantha F. ;
Habel, Laurel A. .
DIABETES CARE, 2011, 34 (04) :923-929
[50]   Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture [J].
Fröhlich, E ;
Machicao, F ;
Wahl, R .
ENDOCRINE-RELATED CANCER, 2005, 12 (02) :291-303